Something not talked about at all lately. Leronli
Post# of 148277
Leronlimab for mild/moderate covid-19.
Especially with all the new strands of the virus.
Yes, for m/m there is lots of competition.
But Leronlimab may well stand as the superior one for m/m???
This market is and will remain huger.